Ovoca Bio plc
OVB.L · LSE
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | -£0 | -£0 | -£0 | £0 |
| Revenue | – | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | – | £0 | £0 | £0 |
| % Margin | – | – | – | – |
| EBITDA | – | -£0 | £0 | -£0 |
| % Margin | – | – | – | – |
| Net Income | – | -£0 | -£0 | -£0 |
| % Margin | – | – | – | – |
| EPS Diluted | – | -0.013 | -0.048 | -0.015 |
| % Growth | – | 72.1% | -228.8% | – |
| Operating Cash Flow | £0 | -£0 | – | -£0 |
| Capital Expenditures | £0 | £0 | – | £0 |
| Free Cash Flow | £0 | -£0 | – | -£0 |